Literature DB >> 6350180

Cellular immunity to Legionella pneumophila in guinea pigs assessed by direct and indirect migration inhibition reactions in vitro.

H Friedman, R Widen, I Lee, T Klein.   

Abstract

Spleen cell cultures from guinea pigs given legionella pneumophila vaccine in complete Freund adjuvant or as a sublethal infection were inhibited in their migration activity in vitro when incubated with specific antigen. Both direct and indirect migration inhibition assays revealed sensitization of the guinea pigs to the bacterium, with demonstrable reactivity 25 to 40 days or more after sensitization. No consistent reactions occurred when the guinea pigs were given the killed Legionella vaccine in incomplete Freund adjuvant in saline. However, spleen cells from guinea pigs injected with sublethal doses of the Legionella vaccine 3 to 4 weeks earlier showed positive migration inhibition factor reactivity. Cutaneous hypersensitivity and lymphocyte blastogenic responsiveness in vitro also developed in guinea pigs sensitized with killed Legionella vaccine in complete adjuvant or given a sublethal infection with the bacterium. These results indicate that in vitro assays for migration inhibitory activity may be utilized to monitor the development of the sensitization of guinea pigs to L. pneumophila, and such reactions correlate with skin reactivity and in vitro lymphocyte blastogenic responses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6350180      PMCID: PMC264617          DOI: 10.1128/iai.41.3.1132-1137.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Lymphocyte transformation to Legionella pneumophila.

Authors:  J F Plouffe; I M Baird
Journal:  J Clin Lab Immunol       Date:  1981-05

2.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

3.  Immune defenses against Legionella pneumophila in rats.

Authors:  B Rolstad; B P Berdal
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

4.  Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

5.  Agar microdroplet assay for delayed hypersensitivity to Legionella pneumophila serogroup 1.

Authors:  R Widen; T Klein; I Lee; H Friedman
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

6.  New bacterial agent of pneumonia isolated from renal-transplant recipients.

Authors:  A W Pasculle; R L Myerowitz; C R Rinaldo
Journal:  Lancet       Date:  1979-07-14       Impact factor: 79.321

7.  Detection of antibodies to Legionella pneumophila in immune guinea pig serum by solid-phase immunofluorescence.

Authors:  F R Vogel; T W Klein; S C Specter; M Hitchings; H Friedman
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

8.  The prevalence of serum antibodies to Legionella pneumophila in patients with chronic pulmonary disease.

Authors:  A P Freedman; S M Katz
Journal:  Am Rev Respir Dis       Date:  1981-02

9.  In vitro responses of guinea pig peritoneal macrophages to Legionella pneumophila.

Authors:  R A Kishimoto; J D White; F G Shirey; V G McGann; R F Berendt; E W Larson; K W Hedlund
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

10.  Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  5 in total

1.  Immunostimulation by Legionella pneumophila antigen preparations in vivo and in vitro.

Authors:  H Friedman; R Widen; T Klein; W Johnson
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

2.  Macrophage-activating T-cell factor(s) produced in an early phase of Legionella pneumophila infection in guinea pigs.

Authors:  Y Nikaido; S Yoshida; Y Goto; Y Mizuguchi; A Kuroiwa
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

3.  In vivo regulation of replicative Legionella pneumophila lung infection by endogenous interleukin-12.

Authors:  J K Brieland; D G Remick; M L LeGendre; N C Engleberg; J C Fantone
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

4.  Relative potency of virulent versus avirulent Legionella pneumophila for induction of cell-mediated immunity.

Authors:  T W Klein; H Friedman; R Widen
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

Review 5.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.